<DOC>
	<DOCNO>NCT00927979</DOCNO>
	<brief_summary>In prospective , randomize , placebo control double-blinded study study efficacy intraperitoneal ropivacaine nebulization pain relief gynecologic laparoscopic surgery . This second steady protocol general anesthesia use Remifentanil .</brief_summary>
	<brief_title>Pain Relief Intra-Peritoneal Nebulization Ropivacaine Under Remifentanil Anesthesia Gynecological Laparoscopy</brief_title>
	<detailed_description>Outcome Measures : - VAS score - Use analgesic operation postoperative period</detailed_description>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Elective gynecological laparoscopic surgery include unilateral bilateral salpingooophorectomy ovarian cystectomy Patient participate medical study present last 30 day Patient capable reading , understand signing informed consent Age 18 year ASA physical status grade 12 Allergy ropivacaine local anesthetic medication list protocol Acute pelvic inflammatory disease Coumadin aspirin treatment Significant arrythmias Analgesic treatment chronic pain BMI &gt; 35</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>